Federal Trade Commission

Cancer-Detection Companies Seek To Re-Merge As Regulators Block Deal

U.S. and Europe regulators oppose ‘vertical merger’ of Illumina-Grail. Critics say that will keep cancer detection costs high. The post Cancer-Detection Companies Seek To Re-Merge As Regulators Block Deal appeared…

Read More »